Concepedia

Aleksi Suo

AS

Statistics

Publications

7

Citations

218

H-Index

7

Active since

2017

Affiliations

University of Calgary(Current)

University of Alberta

Aleksi Suo is an author at University of Calgary specializing in oncology, immunotherapy, and cancer immunotherapy.

Publications per year

2017–2023

7

Publications

7

Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma

Aleksi Suo, Yin Chan, Carissa Beaulieu et al. · The Oncologist · 2020 · 79 citations · Full text

, , +17

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors

Daniel E. Meyers, Igor Stukalin, Isabelle A. Vallerand et al. · Cancers · 2019 · 76 citations · Full text

, , +17

Machine learning for prediction of cutaneous adverse events in patients receiving anti–PD-1 immunotherapy

Ryan T. Lewinson, Daniel E. Meyers, Isabelle A. Vallerand et al. · Journal of the American Academy of Dermatology · 2020 · 19 citations

, , +12

Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors

Igor Stukalin, Vishal Navani, Mehul Gupta et al. · The Oncologist · 2023 · 14 citations · Full text

, , +17

Outcomes and Drug Costs of Sunitinib Regimens for Metastatic Renal Cell Carcinoma: A Provincial Population-Based Study

Aleksi Suo, Urooj Iqbal, June Lim et al. · Clinical Genitourinary Cancer · 2017 · 10 citations

, , +15

1–5 of 7